跳至主要内容
临床试验/NL-OMON38184
NL-OMON38184已完成3 期

Pharmacological Treatment in Hand Osteoarthritis - FABIO

Maasstadziekenhuis0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age * 40 years
  • Primary hand OA according to the ACR classification
  • Heberden or Bouchard nodule or Kellgren-Lawrence grade 1, 2 or 3 in * 2 symptomatic joints
  • Pain in the dominant hand * 12 months
  • Use of an NSAID for * 1 episode of pain
  • Written informed consent

排除标准

  • Secondary hand OA, e.g. hemochromatose, rheumatoid arthritis, posttraumatic
  • Kellgren-Lawrence grade 4 OA
  • Use of hydroxychloroquine within 3 months before entering the study
  • Use of NSAIDs or corticosteroids within 7 days before entering the study
  • Retinopathy
  • Myastenia Gravis
  • Known allergy or hypersensitivity for hydroxychloroquine

研究者

发起方
Maasstadziekenhuis

相似试验

Pharmacological Treatment in Hand Osteoarthritis | 临床试验